Distress tolerance and perceived cancer-related cognitive impairment in nonmetastatic breast cancer.

IF 4.3 3区材料科学 Q1 ENGINEERING, ELECTRICAL & ELECTRONIC

ACS Applied Electronic Materials Pub Date : 2024-09-23 DOI:10.1037/hea0001417

Estefany Saez-Clarke, Emily A Walsh, Padideh Lovan, Rachel Plotke, Molly Ream, Paula Popok, Dolores Perdomo, Bonnie Blomberg, Michael H Antoni

{"title":"Distress tolerance and perceived cancer-related cognitive impairment in nonmetastatic breast cancer.","authors":"Estefany Saez-Clarke, Emily A Walsh, Padideh Lovan, Rachel Plotke, Molly Ream, Paula Popok, Dolores Perdomo, Bonnie Blomberg, Michael H Antoni","doi":"10.1037/hea0001417","DOIUrl":null,"url":null,"abstract":"Objective: Cancer- and cancer treatment-related cognitive impairment (CRCI) is reported by many women with breast cancer (BC). Distress tolerance (DT) refers to both the perceived capacity and behavioral act of withstanding uncomfortable/aversive/negative emotional and/or physical experiences. Poor DT has been associated with worse cognitive performance, including executive dysfunction. Importantly, DT can be improved through psychological interventions. However, DT research in cancer has been limited. This study aimed to examine the relationship between DT and CRCI in women with BC.Method: Women with nonmetastatic BC (n = 107, age ≥ 50 years) were recruited between 2016 and 2023, post BC surgery (54.2% lumpectomy and 38.3% mastectomy) but prior to adjuvant therapy, completed the Distress Tolerance Scale and the Functional Assessment of Cancer Therapy-Cognitive Scale, self-report measures of DT and CRCI, respectively. Hierarchical linear regression was used to test the associations between the DTS-Total Score (DTS-T) and CRCI on the Functional Assessment of Cancer Therapy-Cognitive subscales.Results: DTS-T was significantly associated with perceived cognitive impairment (CogPCI, p = .015), perceived cognitive abilities (CogPCA, p < .001), and quality of life impact (CogQOL, p = .010), after controlling for age and days since surgery. DTS-T explained 12%, 27%, and 12% of the variance in CogPCI, CogPCA, and CogQOL, respectively.Conclusion: Women with BC with greater ability to tolerate distress reported less CRCI, including less CogPCI, less CogQOL, and better CogPCA. Future directions should involve the use of objective measures of CRCI and longitudinal testing of its association with DT. (PsycInfo Database Record (c) 2024 APA, all rights reserved).","PeriodicalId":3,"journal":{"name":"ACS Applied Electronic Materials","volume":null,"pages":null},"PeriodicalIF":4.3000,"publicationDate":"2024-09-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACS Applied Electronic Materials","FirstCategoryId":"102","ListUrlMain":"https://doi.org/10.1037/hea0001417","RegionNum":3,"RegionCategory":"材料科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENGINEERING, ELECTRICAL & ELECTRONIC","Score":null,"Total":0}

引用次数: 0

Abstract

Objective: Cancer- and cancer treatment-related cognitive impairment (CRCI) is reported by many women with breast cancer (BC). Distress tolerance (DT) refers to both the perceived capacity and behavioral act of withstanding uncomfortable/aversive/negative emotional and/or physical experiences. Poor DT has been associated with worse cognitive performance, including executive dysfunction. Importantly, DT can be improved through psychological interventions. However, DT research in cancer has been limited. This study aimed to examine the relationship between DT and CRCI in women with BC.

Method: Women with nonmetastatic BC (n = 107, age ≥ 50 years) were recruited between 2016 and 2023, post BC surgery (54.2% lumpectomy and 38.3% mastectomy) but prior to adjuvant therapy, completed the Distress Tolerance Scale and the Functional Assessment of Cancer Therapy-Cognitive Scale, self-report measures of DT and CRCI, respectively. Hierarchical linear regression was used to test the associations between the DTS-Total Score (DTS-T) and CRCI on the Functional Assessment of Cancer Therapy-Cognitive subscales.

Results: DTS-T was significantly associated with perceived cognitive impairment (CogPCI, p = .015), perceived cognitive abilities (CogPCA, p < .001), and quality of life impact (CogQOL, p = .010), after controlling for age and days since surgery. DTS-T explained 12%, 27%, and 12% of the variance in CogPCI, CogPCA, and CogQOL, respectively.

Conclusion: Women with BC with greater ability to tolerate distress reported less CRCI, including less CogPCI, less CogQOL, and better CogPCA. Future directions should involve the use of objective measures of CRCI and longitudinal testing of its association with DT. (PsycInfo Database Record (c) 2024 APA, all rights reserved).

查看原文本刊更多论文

非转移性乳腺癌患者的压力耐受性和感知到的癌症相关认知障碍。

目的：许多患有乳腺癌（BC）的妇女都报告了与癌症和癌症治疗相关的认知障碍（CRCI）。压力耐受（DT）是指承受不舒服/厌恶/负面情绪和/或身体体验的感知能力和行为。较差的 DT 与较差的认知表现（包括执行功能障碍）有关。重要的是，DT 可以通过心理干预得到改善。然而，针对癌症的 DT 研究还很有限。本研究旨在研究患有 BC 的女性患者的 DT 与 CRCI 之间的关系：方法：在2016年至2023年期间招募了非转移性BC女性患者（n = 107，年龄≥50岁），她们均在BC手术后（54.2%为肿块切除术，38.3%为乳房切除术）但在辅助治疗前完成了压力耐受量表（Distress Tolerance Scale）和癌症治疗功能评估认知量表（Functional Assessment of Cancer Therapy-Cognitive Scale），这两个量表分别是DT和CRCI的自我报告测量指标。我们使用层次线性回归法检验了DTS-总分（DTS-T）与癌症治疗功能评估-认知分量表中CRCI之间的关联：结果：在控制了年龄和术后天数后，DTS-T与认知障碍感知（CogPCI，p = .015）、认知能力感知（CogPCA，p < .001）和生活质量影响（CogQOL，p = .010）明显相关。DTS-T分别解释了12%、27%和12%的CogPCI、CogPCA和CogQOL变异：结论：患有BC的妇女对痛苦的耐受能力较强，她们报告的CRCI较低，包括CogPCI较低、CogQOL较低和CogPCA较好。未来的研究方向应包括使用客观的 CRCI 测量方法，并对其与 DT 的关系进行纵向测试。(PsycInfo Database Record (c) 2024 APA，保留所有权利）。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

ACS Applied Electronic Materials Multiple-

CiteScore

7.20

自引率

4.30%

发文量

567